Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co 13F holdings
Ronald Muhlenkamp's Portfolio
- Portfolio value:
- $213.55M~
- # of securities:
- 28 (-8)
- Reported for:
- 30 Jun 2022 (Q2)
- Latest filing date:
- 18 Jul 2022
What stocks did Ronald Muhlenkamp own in 2022 Q2?
What was Ronald Muhlenkamp's 2022 Q2 portfolio?
Muhlenkamp & Co has disclosed a total of 28 security holdings in their (2022 Q2) SEC 13F filing(s) with portfolio value of $213,553,000.
Muhlenkamp & Co's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ronald Muhlenkamp's original 13F reports (2022 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
28 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
EQT Corp
|
7.16%
|
444,702
|
$34.40
|
+56.71%($53.91)
|
$15,298,000
|
2021 Q4
|
~0.75 years
|
-0.47% (-2.11K)
|
-0.03%
|
|
|
|
Occidental Petroleum Corp
|
6.40%
|
231,962
|
$58.88
|
+1.66%($59.86)
|
$13,658,000
|
2022 Q1
|
~0.50 years
|
-0.28% (-645)
|
-0.01%
|
|
|
|
UnitedHealth Group Incorporated
|
5.90%
|
24,524
|
$513.62
|
-22.71%($396.96)
|
$12,596,000
|
2016 Q1
|
~6.00 years
|
+0.18% (+43)
|
+0.01%
|
|
|
|
McKesson Corp
|
5.79%
|
37,924
|
$326.21
|
+165.34%($865.56)
|
$12,371,000
|
2016 Q2
|
~5.75 years
|
-42.18% (-27.66K)
|
-3.14%
|
|
|
|
Rush Enterprises A Inc
|
5.43%
|
240,406
|
$48.20
|
+62.19%($78.18)
|
$11,588,000
|
2013 Q2*
|
> 8 years
|
|
|
|
|
|
Dow Inc
|
5.25%
|
217,376
|
$51.61
|
-39.25%($31.36)
|
$11,219,000
|
2019 Q2
|
~3.00 years
|
-0.32% (-702)
|
-0.01%
|
|
|
|
Schlumberger NV
|
5.20%
|
310,543
|
$35.76
|
+49.61%($53.50)
|
$11,105,000
|
2020 Q4
|
~1.75 years
|
-0.24% (-754)
|
-0.01%
|
|
|
|
Berkshire Hathaway Inc
|
4.76%
|
37,194
|
$273.03
|
+83.81%($501.85)
|
$10,155,000
|
2019 Q3
|
~2.75 years
|
+0.21% (+78)
|
+0.01%
|
|
|
|
CVS Health Corp
|
4.73%
|
108,923
|
$92.66
|
+0.39%($93.02)
|
$10,093,000
|
2019 Q3
|
~2.75 years
|
-0.10% (-114)
|
-0%
|
|
|
|
Kirby Corp
|
4.67%
|
163,915
|
$60.84
|
+126.96%($138.09)
|
$9,973,000
|
2020 Q3
|
~2.00 years
|
-0.90% (-1.48K)
|
-0.03%
|
|
Completely sold out
8 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
WESCO International Inc
|
-78,911
|
-3.58%
|
2020 Q4
|
~1.50 years
|
|
|
|
Lockheed Martin Corp
|
-19,605
|
-3.01%
|
2019 Q3
|
~2.50 years
|
|
|
|
Meritage Corp
|
-97,114
|
-2.68%
|
2019 Q2
|
~2.75 years
|
|
|
|
Lennar Corp
|
-68,866
|
-1.95%
|
2019 Q4
|
~2.25 years
|
|
|
|
Equity Commonwealth
|
-113,328
|
-1.11%
|
2021 Q3
|
~0.75 years
|
|
|
|
LOYALTY VENTURES INC
|
-50,047
|
-0.29%
|
2021 Q4
|
~0.50 years
|
|
|
|
Invesco BuyBack Achievers ETF
|
-5,699
|
-0.18%
|
2021 Q4
|
~0.50 years
|
|
|
|
SPDR Portfolio TIPS
|
-7,797
|
-0.08%
|
2022 Q1
|
~0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".
* % of portfolio: the total can exceed 100%, e.g. when there are also options positions, which can be short.